Exicom Tele-Systems Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
EXICOM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Exicom Tele-Systems has submitted nil deviation statements for both its IPO (Rs. 400 crore raised in Dec 2023/Feb 2024) and Rights Issue (Rs. 259.41 crore raised in July 2025). For the IPO, Rs. 391.17 crore has been utilized out of Rs. 400 crore raised, with R&D receiving Rs. 31.17 crore of its Rs. 40 crore allocation. The manufacturing facility in Telangana (Rs. 151.47 crore) and debt repayment (Rs. 50.30 crore) are fully utilized. The Rights Issue funds are fully deployed at Rs. 259.41 crore, primarily for subsidiary investment (Tritium Business) and debt repayment. Both statements were reviewed and approved by the Audit Committee, with monitoring by CARE Ratings.
Both fundraisings are on track with no misuse of proceeds. The nil deviation filing is a routine compliance matter and indicates proper fund deployment, which is positive for investor confidence. The R&D allocation shows some unutilized amount but this is within normal course.